AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26482004 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based, nurse-led health program (family-care team provision, physiological rehabilitation, emotion-release management, informal social support system, and follow-up monitoring)
Number of subjects: 226
Study 26482004 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing education
Number of subjects: 226
Study 24506226 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft Seal®
Number of subjects: 40
Study 24506226 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel™
Number of subjects: 40
Study 24506226 — intervention group
Group type: EXPERIMENTAL
Intervention: AuraOnce™
Number of subjects: 40
Study 24506226 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chest compressions
Number of subjects: 40
Study 23134222 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine-depleted lake trout injected with TNP-LPS
Number of subjects: 0
Study 23134222 — intervention group
Group type: COMPARATOR
Intervention: Thiamine-replete lake trout injected with TNP-KLH
Number of subjects: 0
Study 23134222 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine-depleted lake trout injected with TNP-KLH
Number of subjects: 0
Study 23134222 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine-depleted lake trout
Number of subjects: 0
Study 23134222 — intervention group
Group type: COMPARATOR
Intervention: Thiamine-replete lake trout
Number of subjects: 0
Study 20130603 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine/methotrexate (MTX) maintenance therapy
Number of subjects: 59
Study 19230269 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory intervention based on self-efficacy
Number of subjects: 0
Study 19230269 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 16706649 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant/NO‐modulating fermented papaya preparation (FPP) 9 g/day for 4 weeks
Number of subjects: 12
Study 16706649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12710789 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-elevated position
Number of subjects: 55
Study 12710789 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 55
Study 10843451 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG plus epirubicin
Number of subjects: 41
Study 10843451 — intervention group
Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 41
Study 9166203 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment
Number of subjects: 435
Study 9166203 — intervention group
Group type: COMPARATOR
Intervention: Deferred treatment
Number of subjects: 435
Study 8404096 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PY) 30 mg orally three times a day
Number of subjects: 30
Study 8404096 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 3780824 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 1 and 2 mg/kg i.v. X 5
Number of subjects: 15
Study 3780824 — intervention group
Group type: COMPARATOR
Intervention: Standard antiemetics in low doses on demand
Number of subjects: 15
Study 3780824 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reporting of nausea using a visual analogue scale (VAS)
Number of subjects: 15
Study 3780824 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose metoclopramide
Number of subjects: 15
Study 29204710 — intervention group
Group type: EXPERIMENTAL
Intervention: SymptomCare@Home (SCH)
Number of subjects: 252
Study 27576880 — intervention group
Group type: EXPERIMENTAL
Intervention: PCNL using split Amplatz sheath (group 2)
Number of subjects: 72
Study 27576880 — intervention group
Group type: COMPARATOR
Intervention: PCNL using intact Amplatz sheath (group 1)
Number of subjects: 72
Study 25007868 — intervention group
Group type: COMPARATOR
Intervention: Group B: 120 kV, 40 % ASIR
Number of subjects: 44
Study 25007868 — intervention group
Group type: COMPARATOR
Intervention: Group C: 100 kV, 40 % ASIR
Number of subjects: 44
Study 25007868 — intervention group
Group type: COMPARATOR
Intervention: Group D: 80 kV, 40 % ASIR
Number of subjects: 44
Study 22631865 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postpartum etonogestrel implant (IPI) insertion
Number of subjects: 396
Study 22631865 — intervention group
Group type: COMPARATOR
Intervention: Other methods (control group)
Number of subjects: 396
Study 20400451 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal Dialysis (PD)
Number of subjects: 140
Study 20400451 — intervention group
Group type: COMPARATOR
Intervention: Haemodialysis (HD)
Number of subjects: 140
Study 17924051 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis diagnosis
Number of subjects: 2187
Study 17924051 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with bisphosphonates
Number of subjects: 2187
Study 17924051 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and/or vitamin D supplementation
Number of subjects: 2187
Study 17924051 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for hip fractures
Number of subjects: 2187
Study 17924051 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated men with clinical fragility fractures
Number of subjects: 2187
Study 15915072 — intervention group
Group type: EXPERIMENTAL
Intervention: RV dysfunction with LV/RV <2
Number of subjects: 99
Study 15915072 — intervention group
Group type: COMPARATOR
Intervention: RV dysfunction with LV/RV >=2
Number of subjects: 99
Study 12830461 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 126
Study 12830461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 10650359 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally delivered doxycycline
Number of subjects: 0
Study 10650359 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing
Number of subjects: 0
Study 9252001 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 94
Study 9252001 — intervention group
Group type: COMPARATOR
Intervention: Placebo apparatus
Number of subjects: 94
Study 2005924 — intervention group
Group type: COMPARATOR
Intervention: Primidone
Number of subjects: 15
Study 2005924 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital
Number of subjects: 15
Study 2005924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2005924 — intervention group
Group type: COMPARATOR
Intervention: Primidone and Phenobarbital
Number of subjects: 15
Study 6404289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glyceryl trinitrate
Number of subjects: 85
Study 6404289 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 85
Study 31484028 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent/Adult Sensory Profile (AASP)
Number of subjects: 787
Study 28780512 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg dapirolizumab pegol followed by 15 mg/kg every 2 weeks for 10 weeks
Number of subjects: 24
Study 28780512 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo regimen
Number of subjects: 24
Study 24702239 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration (1.8 mL with 1:100,000 epinephrine)
Number of subjects: 50
Study 24702239 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine inferior alveolar nerve block (1.8 mL with 1:100,000 epinephrine)
Number of subjects: 50
Study 24702239 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration
Number of subjects: 50
Study 24702239 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine inferior alveolar nerve block
Number of subjects: 50
Study 23078578 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation (34 hours without sleep)
Number of subjects: 10
Study 23078578 — intervention group
Group type: COMPARATOR
Intervention: Control (normal sleep from 23:00 to 07:00 h)
Number of subjects: 10
Study 22120094 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 7.5 mg
Number of subjects: 0
Study 22120094 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 15 mg
Number of subjects: 0
Study 22120094 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (control)
Number of subjects: 0
Study 19592176 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Cycloserine (DCS)
Number of subjects: 25
Study 19592176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 16845915 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-nitrous oxide
Number of subjects: 80
Study 16845915 — intervention group
Group type: COMPARATOR
Intervention: Propofol-nitrous oxide
Number of subjects: 80
Study 15533731 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 14
Study 15533731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 11046202 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin solution
Number of subjects: 20
Study 11046202 — intervention group
Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch solution
Number of subjects: 20
Study 9073135 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuous polymeric enteral nutrition (1665 kcal/day, through nasogastric tube)
Number of subjects: 22
Study 9073135 — intervention group
Group type: COMPARATOR
Intervention: Nil by mouth (control group)
Number of subjects: 22
Study 8375360 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase related external suction (PRES) baroreceptor stimulation
Number of subjects: 7
Study 8375360 — intervention group
Group type: COMPARATOR
Intervention: Baroreceptor inhibition
Number of subjects: 7
Study 3531141 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day drug
Number of subjects: 38
Study 3531141 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day drug
Number of subjects: 38
Study 3531141 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day drug (therapeutic)
Number of subjects: 38
Study 3531141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (prophylactic)
Number of subjects: 38
Study 3531141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (therapeutic)
Number of subjects: 38
Study 3531141 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day drug (tolerance study)
Number of subjects: 38
Study 3531141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (tolerance study)
Number of subjects: 38
Study 28993537 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice daily
Number of subjects: 0
Study 28993537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28124590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID-I)
Number of subjects: 200
Study 25581217 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) 0.3g at 37 Hz for 10 minutes daily
Number of subjects: 174
Study 25581217 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham WBV)
Number of subjects: 174
Study 23301010 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory behavioral tasks (including learning tasks with and without visual feedback and simple somatosensory input)
Number of subjects: 40
Study 23301010 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 40
Study 23301010 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback task
Number of subjects: 40
Study 21492437 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 30
Study 21492437 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 30
Study 18571210 — intervention group
Group type: EXPERIMENTAL
Intervention: Olibra fat emulsion (test yoghurt)
Number of subjects: 41
Study 18571210 — intervention group
Group type: COMPARATOR
Intervention: Placebo (test yoghurt)
Number of subjects: 41
Study 17135810 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail-In Cognitive Function Screening Instrument (MCFSI)
Number of subjects: 640
Study 14680080 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg)
Number of subjects: 29
Study 14680080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 14680080 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (200 microg)
Number of subjects: 29
Study 12071899 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP plus information booklet
Number of subjects: 0
Study 12071899 — intervention group
Group type: EXPERIMENTAL
Intervention: Information booklet only
Number of subjects: 0
Study 12071899 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 9686665 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific cellular immunity in children with zoster
Number of subjects: 13
Study 9686665 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (N=8)
Number of subjects: 13
Study 8135446 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical bruit present
Number of subjects: 0
Study 8135446 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical bruit absent
Number of subjects: 0
Study 8135446 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical bruit combined with four other clinical characteristics
Number of subjects: 0
Study 2572251 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol (200 mg twice daily)
Number of subjects: 1000
Study 2572251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 2572251 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (0.125 mg twice daily)
Number of subjects: 1000
Study 31005425 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy (TBC)
Number of subjects: 24
Study 31005425 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy (TBC) after 2015
Number of subjects: 24
Study 27913163 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized reminder/recall (C-R/R)
Number of subjects: 15
Study 27913163 — intervention group
Group type: COMPARATOR
Intervention: Practice-based reminder/recall (PB-R/R)
Number of subjects: 15
Study 25924776 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 150
Study 25924776 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 150
Study 23489394 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised cognitive behavioural therapy (CCBT)
Number of subjects: 0
Study 23489394 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Mental Training (PosMT)
Number of subjects: 0
Study 21235825 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program for 3 years
Number of subjects: 304
Study 21235825 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 304
Study 21235825 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program for 3 years (sub-analysis for BMI > 22.5 kg/m2)
Number of subjects: 304
Study 19234828 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation (tidal volume of 10-12 ml x kg(-1) for 16 hours or more)
Number of subjects: 22
Study 19234828 — intervention group
Group type: COMPARATOR
Intervention: Standard ventilation (tidal volume of 6-8 ml x kg(-1))
Number of subjects: 22
Study 17355378 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy and STD prevention counseling (adapted from motivational interviewing)
Number of subjects: 764
Study 17355378 — intervention group
Group type: COMPARATOR
Intervention: General health counseling (Control)
Number of subjects: 764
Study 15573643 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand care regimen with moisturizer
Number of subjects: 0
Study 15573643 — intervention group
Group type: COMPARATOR
Intervention: Control group using a regimen without moisturizer
Number of subjects: 0
Study 11494079 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg initially, increased to 100 mg or decreased to 25 mg based on efficacy and toleration)
Number of subjects: 236
Study 11494079 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 236
Study 11494079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 9541846 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromid with 370 mg iodine/ml (viscosity 9.9 mPas, osmolality 770 mOsmol/kg H2O)
Number of subjects: 0
Study 9541846 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol with 270 mg iodine/ml (viscosity 5.8 mPas, osmolality 290 mOsmol/kg H2O)
Number of subjects: 0
Study 9541846 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopentol with 150 mg iodine/ml (viscosity 1.7 mPas, osmolality 340 mOsmol/kg H2O)
Number of subjects: 0
Study 9541846 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity radiocontrast agents
Number of subjects: 0
Study 7995781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol (10‐15 mg i.v.)
Number of subjects: 9
Study 7995781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous atropine (0.03 mg/kg i.v.)
Number of subjects: 9
Study 7995781 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 9
Study 30219434 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated yoga at 40.5°C (n=21)
Number of subjects: 54
Study 30219434 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoneutral yoga at 23°C (n=14)
Number of subjects: 54
Study 30219434 — intervention group
Group type: COMPARATOR
Intervention: Time control (n=19)
Number of subjects: 54
Study 27759410 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionator with expansion screw
Number of subjects: 42
Study 27759410 — intervention group
Group type: EXPERIMENTAL
Intervention: All-patient group
Number of subjects: 42
Study 24682346 — intervention group
Group type: EXPERIMENTAL
Intervention: MPCs (25 million)
Number of subjects: 30
Study 24682346 — intervention group
Group type: COMPARATOR
Intervention: Control (medium)
Number of subjects: 30
Study 22132809 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day
Number of subjects: 65
Study 22132809 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose capsule)
Number of subjects: 65
Study 20592514 — intervention group
Group type: EXPERIMENTAL
Intervention: UW Cores system
Number of subjects: 14
Study 20592514 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 20592514 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention team
Number of subjects: 14
Study 18243581 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG)
Number of subjects: 2311
Study 18243581 — intervention group
Group type: COMPARATOR
Intervention: Reading achievement program
Number of subjects: 2311
Study 18243581 — intervention group
Group type: COMPARATOR
Intervention: Standard program
Number of subjects: 2311
Study 16183442 — intervention group
Group type: EXPERIMENTAL
Intervention: Bullard laryngoscopy
Number of subjects: 21
Study 16183442 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscopy
Number of subjects: 21
Study 12834519 — intervention group
Group type: EXPERIMENTAL
Intervention: EXER (supervised exercise training)
Number of subjects: 28
Study 12834519 — intervention group
Group type: COMPARATOR
Intervention: HOME (home exercise program)
Number of subjects: 28
Study 12834519 — intervention group
Group type: EXPERIMENTAL
Intervention: EXER
Number of subjects: 28
Study 12834519 — intervention group
Group type: COMPARATOR
Intervention: HOME
Number of subjects: 28
Study 10371541 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen treatment
Number of subjects: 0
Study 10371541 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual dose escalation of interferon beta-1b
Number of subjects: 0
Study 10371541 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ibuprofen treatment and gradual dose escalation of interferon beta-1b
Number of subjects: 0
Study 10371541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8664112 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiation therapy (CHART)
Number of subjects: 1481
Study 8664112 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (Control)
Number of subjects: 1481
Study 8664112 — intervention group
Group type: EXPERIMENTAL
Intervention: CHART
Number of subjects: 1481
Study 1768559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 12.5 mg i.v.
Number of subjects: 0
Study 1768559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 50 mg oral
Number of subjects: 0
Study 1768559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 25 mg twice daily for 14 days
Number of subjects: 0
Study 1768559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) single doses
Number of subjects: 0
Study 6344550 — intervention group
Group type: EXPERIMENTAL
Intervention: Urabe Am 9 strain of live attenuated mumps vaccine
Number of subjects: 118
Study 6344550 — intervention group
Group type: COMPARATOR
Intervention: Jeryl Lynn strain of live attenuated mumps vaccine
Number of subjects: 118
Study 31427751 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulatory drugs (Anti-IL-6 antibodies)
Number of subjects: 10743
Study 31427751 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulatory drugs (Anti-IL-12/23 antibody)
Number of subjects: 10743
Study 31427751 — intervention group
Group type: COMPARATOR
Intervention: Immunomodulatory drugs (general)
Number of subjects: 10743
Study 27511921 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR) program
Number of subjects: 200
Study 27511921 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 200
Study 27543343 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus six sessions of clinical emotional freedom techniques (EFT)
Number of subjects: 21
Study 27543343 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) wait-list group
Number of subjects: 21
Study 24291366 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5mg daily
Number of subjects: 209
Study 24291366 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 209